FunPep Company Limited Logo

FunPep Company Limited

Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.

4881 | T

Overview

Corporate Details

ISIN(s):
JP3802640007
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ七丁目7−15
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

FunPep Company Limited is a clinical-stage biotechnology company that originated as a spin-out from Osaka University. The company specializes in the research and development of therapeutics based on its proprietary functional peptide and antibody-inducing peptide platform technologies. Its core business is creating novel peptide-based pharmaceutical products. FunPep's development pipeline includes candidates for various indications, such as an allergy vaccine and the functional peptide SR-0379 for intractable ulcers, which has advanced to late-stage clinical trials. The company's business scope also extends to the development of functional cosmetics and medical devices, leveraging the diverse applications of its core peptide technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:30
Report Publication Announcement
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第13期(2025/01/01-2025/12/31)
Japanese 278.9 KB
2025-04-01 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-03-28 08:16
Registration Form
確認書
Japanese 8.5 KB
2025-03-28 08:15
Annual Report
有価証券報告書-第12期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:15
Governance Information
内部統制報告書-第12期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-02-21 07:30
Registration Form
有価証券届出書(組込方式)
Japanese 447.3 KB
2024-08-08 09:01
Report Publication Announcement
確認書
Japanese 8.4 KB
2024-08-08 09:00
Interim Report
半期報告書-第12期(2024/01/01-2024/12/31)
Japanese 283.1 KB
2024-08-08 03:00
Major Shareholding Notification
臨時報告書
Japanese 21.3 KB
2024-07-05 08:05
Registration Form
有価証券届出書(組込方式)
Japanese 391.3 KB
2024-05-13 08:00
Quarterly Report
確認書
Japanese 8.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第12期第1四半期(2024/01/01-2024/03/31)
Japanese 238.2 KB
2024-04-01 08:05
Post-Annual General Meeting Information
臨時報告書
Japanese 27.7 KB
2024-03-28 07:15
Registration Form
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all FunPep Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FunPep Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FunPep Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea
216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan
7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France
IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan
3970
Innventure, Inc. Logo
Founds, funds, and scales companies using breakthrough R&D from multinational corporations.
United States of America
INV
Inotiv, Inc. Logo
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan
4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC

Talk to a Data Expert

Have a question? We'll get back to you promptly.